Prognoza

Nie mamy danych analityków dla tej spółki.

Dyskusje w społeczności

Nie ma jeszcze dyskusji o tym aktywie.

Rozpocznij dyskusję

  • Zentek corrects weekday for OTC trading start to Wednesday, September 2, 2026

    Zentek corrects a previous notice: trading in common shares on the OTC Markets is expected to begin on Wednesday, September 2, 2026 (date was correct, weekday was wrong). The company has applied for a listing on the OTCQX, expects a new U.S. trading symbol (different from ZTEK) and plans a provisional listing in the initial trading tier pending a decision. The TSX Venture Exchange remains the primary listing under the ticker ZEN; shareholders do not need to take any action and their holdings will remain unchanged. » Więcej na de.investing.com


  • Zentek moves to the OTC Markets after Nasdaq delisting

    Zentek announced that its common shares will move from the Nasdaq Capital Market to the OTC Markets Group effective September 2, 2026, after failing to meet Nasdaq’s minimum bid price requirement. The company said it will request a hearing to contest the delisting, which will not prevent the suspension of trading. The shares will remain listed on the TSX Venture Exchange under the symbol ZEN and shareholders do not need to take any action. Zentek has applied for listing on the OTCQX Best Market and will continue to report business and financial results as usual. » Więcej na de.investing.com


  • Zentek receives standing-offer contract from the Government of Canada for ZenGUARD air filters

    Zentek has been awarded a standing-offer contract with the Government of Canada to supply HVAC filters, including the ZenGUARD Enhanced Air Filter, for federal sites in the National Capital Region. The contract runs from August 19, 2026, to August 18, 2027, with a maximum value of 348,666.84 CAD and pre-set prices for ministry call-ups. National Research Council of Canada tests showed about a fivefold improvement in aerosol filtration performance; a pilot project yielded 22% lower fan energy use versus conventional MERV-13 pleated filters. In May 2026 ZenGUARD was added to Innovative Solutions Canada’s “Pathway to Commercialization” procurement list, listing Zentek as a potential exclusive supplier for federal sites, without a minimum purchase guarantee. » Więcej na de.investing.com


  • Zentek files provisional patent application for electromagnetic shielding coating

    Zentek has filed a provisional application with the US Patent Office for ZEN-EMI-01, a water-based shielding coating made from Albany graphite, ferrite particles and a conductive polymer. Internal tests showed that a thin layer predominantly attenuates microwaves in the 8–12 GHz band by absorption; these results have not been independently verified. The filing establishes a priority date and starts a twelve-month period for international filings; the development program includes third-party testing, formulation optimization, qualification tests and scale-up, so far without customer contracts. » Więcej na de.investing.com


  • Zentek hires IMPAQ Capital for investor relations in North America

    Zentek has engaged IMPAQ Capital to manage communications with investment professionals in North America. The agreement begins immediately, initially runs for six months and automatically renews for three-month periods; IMPAQ will receive C$13,500 per month and no securities will be issued. The engagement is subject to approval by the TSX Venture Exchange; Zentek is currently trading with a market capitalization of $44.8m at $0.06 per share and remains unprofitable despite revenues of $1.68m in the last twelve months. » Więcej na de.investing.com

W 2023 roku Zentek Aktie wypłaciła już 0,94 € dywidend. Ostatnia wypłata nastąpiła w wrzesień 2023.

Dane finansowe

W ostatnim kwartale Zentek Aktie osiągnęła przychody w wysokości 0 € i zysk netto w wysokości -1,26 mln €

(EUR) czerwiec 2026
YoY
Przychody 0 100,00%
Zysk brutto -754,14 tys. 4547,07%
Zysk netto -1,26 mln 48,43%
EBITDA -1,27 mln 75,01%

Dane fundamentalne

Wskaźnik Wartość
Kapitalizacja rynkowa
56,77 mln €
Liczba akcji
126,62 mln
Maksimum/minimum z 52 tygodni
1,00 € - 0,33 €
Dywidendy Nie
Beta
0,29
C/Z (PE Ratio)
7,99
PEG (PEG Ratio)
0,07
C/WK (PB Ratio)
1,57
C/S (PS Ratio)
625,73

Profil spółki

Zentek Ltd. prowadzi badania i rozwój w zakresie grafenu i pokrewnych nanomateriałów w Kanadzie. Posiada 100% udziałów w projekcie Albany Graphite położonym w Northern Ontario w Kanadzie. Spółka opracowuje powłokę antymikrobiologiczną na bazie grafenu oraz maseczki chirurgiczne, filtry HVAC i sprzęt ochrony osobistej. Firma prowadzi również prace nad syntezą grafenu, tlenku grafenu i kwantowych kropek grafenowych do zastosowań w obszarze grafenu. Spółka wcześniej funkcjonowała pod nazwą ZEN Graphene Solutions Ltd. i zmieniła nazwę na Zentek Ltd. w październiku 2021 roku. Zentek Ltd. został założony w 2008 roku i ma siedzibę w Thunder Bay w Kanadzie.

Nazwa
Zentek Aktie
CEO
Mohammed Jiwan
Siedziba Guelph, on
Kanada
Strona internetowa
Sektor
Materiały podstawowe
Branża
Chemikalia
Debiut giełdowy
14.11.2016
Pracownicy 10

Symbole giełdowe

Giełda Symbol
NASDAQ
ZTEK
Tsxv
ZEN.V
Frankfurt
ZAY0.F
Düsseldorf
ZAY0.DU
München
ZAY0.MU
🍪

Parqet  używa plików cookie. Dowiedz się więcej